1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. CAPLIN POINT LABORATORIES LTD.
Caplin Point Laboratories Ltd. NSE: CAPLIPOINT | BSE: 524742
1672.90 -27.20 (-1.60%)
93,822
NSE+BSE Volume

NSE 02 Mar, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert

US FDA Approval
Caplin Point's arm gets US FDA nod for Desmopressin Acetate injection, with US sales of ~$26 mn See details


Caplin Point Labs Earnings/Conference Calls

Caplin Point Labs earnings concalls and investor presentations

492 Votes:
Buy 80.89%
Sell 12.2%
Hold 6.91%
BUY
SELL
HOLD